The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sustained impact of primary platinum-free interval and BRCA1/2 mutation status on survival in patients with ovarian cancer after multiple lines of therapy.
 
Michael A. Bookman
Employment - McKesson
Honoraria - Genentech/Roche; Genentech/Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Clovis Oncology; Endocyte; Genentech/Roche; Genentech/Roche; Gradalis; Immunogen; Novartis; Oxigene; Pfizer; Sanofi; Tesaro; Vertex
 
Jerzy E. Tyczynski
Employment - AstraZeneca
Leadership - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Janet L. Espirito
Employment - McKesson
 
Thomas Wilson
Employment - McKesson
Leadership - Trajectory Healthcare
Stock and Other Ownership Interests - Trajectory Healthcare
Consulting or Advisory Role - McKesson
Patents, Royalties, Other Intellectual Property - Patent holder: US patents 7,685,011, 7,685,012. Royalty sharing agreement between patent holder and licensee, Trajectory Healthcare, LLC
 
Ancilla Fernandes
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca